Conference summary

What we have learned and where we are headed

    Research output: Contribution to journalArticle

    Abstract

    This overview highlights the actionable near-term objectives for the TRN drawn from discussions in the breakout sessions. A major purpose of the symposium was to focus attention on establishing priorities, setting goals, and identifying the steps toward accomplishing those goals. Two major objectives were identified. One is to establish Turner syndrome as a priority area of research for the National Institutes of Health. Turner syndrome should not only be viewed as a rare disorder, but also as a model for common diseases that have a male sex bias in the general population attributable to the lack of a second X chromosome. Barriers to recognition of Turner syndrome as an important area of research were identified, and new approaches to enhancing visibility are discussed. The second major objective is to further development of the Turner Syndrome Research Registry (TSRR). This patient-powered research registry is a paradigm-shifting model for how human-based research can be improved through equal partnerships between researchers and study subjects. The TSRR is founded on an agreement that study participants are the ultimate owners of their personal data. The major challenges to establishing a maximally functional registry of this design were discussed, and a clear path forward was established.

    Original languageEnglish (US)
    JournalAmerican Journal of Medical Genetics, Part C: Seminars in Medical Genetics
    DOIs
    StateAccepted/In press - Jan 1 2019

    Fingerprint

    Turner Syndrome
    Registries
    Research
    Sexism
    National Institutes of Health (U.S.)
    X Chromosome
    Research Personnel
    Population

    ASJC Scopus subject areas

    • Genetics
    • Genetics(clinical)

    Cite this

    @article{5310f1e92c494f9ba0805fca8f4b0c22,
    title = "Conference summary: What we have learned and where we are headed",
    abstract = "This overview highlights the actionable near-term objectives for the TRN drawn from discussions in the breakout sessions. A major purpose of the symposium was to focus attention on establishing priorities, setting goals, and identifying the steps toward accomplishing those goals. Two major objectives were identified. One is to establish Turner syndrome as a priority area of research for the National Institutes of Health. Turner syndrome should not only be viewed as a rare disorder, but also as a model for common diseases that have a male sex bias in the general population attributable to the lack of a second X chromosome. Barriers to recognition of Turner syndrome as an important area of research were identified, and new approaches to enhancing visibility are discussed. The second major objective is to further development of the Turner Syndrome Research Registry (TSRR). This patient-powered research registry is a paradigm-shifting model for how human-based research can be improved through equal partnerships between researchers and study subjects. The TSRR is founded on an agreement that study participants are the ultimate owners of their personal data. The major challenges to establishing a maximally functional registry of this design were discussed, and a clear path forward was established.",
    author = "Cheryl Maslen",
    year = "2019",
    month = "1",
    day = "1",
    doi = "10.1002/ajmg.c.31669",
    language = "English (US)",
    journal = "American Journal of Medical Genetics, Part A",
    issn = "1552-4825",
    publisher = "Wiley-Liss Inc.",

    }

    TY - JOUR

    T1 - Conference summary

    T2 - What we have learned and where we are headed

    AU - Maslen, Cheryl

    PY - 2019/1/1

    Y1 - 2019/1/1

    N2 - This overview highlights the actionable near-term objectives for the TRN drawn from discussions in the breakout sessions. A major purpose of the symposium was to focus attention on establishing priorities, setting goals, and identifying the steps toward accomplishing those goals. Two major objectives were identified. One is to establish Turner syndrome as a priority area of research for the National Institutes of Health. Turner syndrome should not only be viewed as a rare disorder, but also as a model for common diseases that have a male sex bias in the general population attributable to the lack of a second X chromosome. Barriers to recognition of Turner syndrome as an important area of research were identified, and new approaches to enhancing visibility are discussed. The second major objective is to further development of the Turner Syndrome Research Registry (TSRR). This patient-powered research registry is a paradigm-shifting model for how human-based research can be improved through equal partnerships between researchers and study subjects. The TSRR is founded on an agreement that study participants are the ultimate owners of their personal data. The major challenges to establishing a maximally functional registry of this design were discussed, and a clear path forward was established.

    AB - This overview highlights the actionable near-term objectives for the TRN drawn from discussions in the breakout sessions. A major purpose of the symposium was to focus attention on establishing priorities, setting goals, and identifying the steps toward accomplishing those goals. Two major objectives were identified. One is to establish Turner syndrome as a priority area of research for the National Institutes of Health. Turner syndrome should not only be viewed as a rare disorder, but also as a model for common diseases that have a male sex bias in the general population attributable to the lack of a second X chromosome. Barriers to recognition of Turner syndrome as an important area of research were identified, and new approaches to enhancing visibility are discussed. The second major objective is to further development of the Turner Syndrome Research Registry (TSRR). This patient-powered research registry is a paradigm-shifting model for how human-based research can be improved through equal partnerships between researchers and study subjects. The TSRR is founded on an agreement that study participants are the ultimate owners of their personal data. The major challenges to establishing a maximally functional registry of this design were discussed, and a clear path forward was established.

    UR - http://www.scopus.com/inward/record.url?scp=85059907352&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85059907352&partnerID=8YFLogxK

    U2 - 10.1002/ajmg.c.31669

    DO - 10.1002/ajmg.c.31669

    M3 - Article

    JO - American Journal of Medical Genetics, Part A

    JF - American Journal of Medical Genetics, Part A

    SN - 1552-4825

    ER -